We use in-house capabilities to develop and commercialize pharmaceutical products for global markets and provide several types of dosage forms. These include tablets, capsules, pellets, powders, drops, inhalers and transdermal patches. Developing with a patient-centered approach we are always searching for the dosage form which serves best patients´ needs.

We at TIEFENBACHER GROUP firmly believe that high-quality medicines should be affordable for all patients around the world – irrespective of their income level. Generic products provide a safe, effective, and cost-efficient alternative to reference brands.

Our generics business lies in the development, production, and commercialization of high-quality medicines following the loss of their respective patent protection, thus helping secure access to affordable, quality healthcare for patients around the world. To offer high-quality generic versions of innovative medicines at a fraction of the costs, we drive efficiency in all our business activities – from efficient API sourcing to a lean inhouse development and manufacturing approach to a global market access.

Value added medicines are designed to help patients to better manage their health condition and ultimately lead to better adherence, health outcomes, and quality of life.  This can include less side effects, a better API absorption, better safety, additional product strengths, or new fix-dose combinations – just to name a few examples of our differentiated products. We are constantly developing new product solutions for reaching an unique selling proposition in the market and bringing added value to patients – always with a patient-centric approach.

Our own laboratories with up-to-date technologies and our exclusive global network of development partners enable us to cover all major therapeutics. This includes respiratory, neuroscience, cardiovascular, renal, metabolism, immunology, hepatology, dermatology, infectious diseases, and ophthalmology.  Based on current market needs we are focusing on the field of oncology. For this specific indication we have already 25 leading highly potent drugs in our launch pipeline which are planned to be developed and produced in-house in our new high-potent facilities in Hyderabad, India. 

We have a team of internationally recognized scientists in Research and Development. Their curiosity, their long-lasting experience, their diversity, and their passion for healthcare are the foundation of our success. Our teams of experts work continuously to optimize processes, increase outputs, and reduce timelines throughout the drug development to market access of high-quality pharmaceuticals worldwide

We have successfully developed and marketed a broad range of pharmaceuticals (including both blockbuster and niche products), many of which are leaders in their respective markets. We provide 180+ FDF-products across various therapeutic categories in 10+ dosage forms including highly potent drugs – and additional medical devices.

Quality assurance (QA) is an integral part of TIEFENBACHER GROUP. It ensures a development process which considers all aspects of quality and customer requirements, transparency, and applying good manufacturing practice (GMP). The development projects are performed following ICH, EU, USFDA and other international guidelines. This enables us to generate a corresponding documentation for the submission of a marketing authorization application in the EU, in the US, and further international territories. Our outstanding inhouse intellectual property (IP) competence is a further backbone to guarantee a development process which meets the diverse requirements of our global target market.

Our research and development operations are supported by our own advanced laboratories in Hyderabad, India. It is a GLP/GMP compliant facility and was successfully inspected by the US FDA authorities, the German BGV, the Russian MIT, and the Turkish Ministry of Health. Most modern techniques and softwares (e. g. inhouse XRD Crystallography, WinNonlin IVIVC simulation tools, Nitrosamine testing, Malvern particle size testing) are part of the state-of-the-art equipment. With our new own high potent lab we are able to develop a well-defined and specialized portfolio of highly potent drug formulations inhouse.

We have successfully developed and marketed a range of products (including both blockbuster and niche products), many of which are leaders in their respective markets. We provide over 180+FDF products across various therapeutic categories in 10+ dosage forms including highly potent drugs – and additional medical devices. We are not limited to specific disease areas – we are focusing on what will truly deliver an impact and value for patients – whether for widespread or for orphan diseases.

We market our products in over 80 countries worldwide. We constantly analyze global markets for innovative business opportunities and use in-house capabilities to develop and commercialize pharmaceutical products for local, multinational, and global out-licensing partners. We are experts in adjusting to specific local requirements and customer challenges to ensure that our healthcare solutions make a sustainable impact – for the benefit of patient around the globe.

We are a purpose-driven and 100% family owned health care company providing best-in-class solutions along the entire pharmaceutical value chain. From initial idea to market access of high-quality pharmaceuticals for people around the world: We distribute APIs and develop, manufacture, and register finished dosage forms including highly potent drugs as well as medical devices

Ever since the company was established by Alfred E. Tiefenbacher in 1963, we are pioneering healthcare to improve patients’ lives around the world. We always challenge the status quo to be one step ahead – in terms of business models as well as concrete products and services. This entrepreneurial spirit is firmly anchored in our founder and owner family being the driving force of achieving better health solutions worldwide

From initial idea to market access of high-quality pharmaceuticals for patients: We distribute APIs and develop, manufacture, and register finished dosage forms (FDF) including highly potent drugs as well as medical devices. Our GMP and GDP approved own facilities in India and Cyprus attest to our high level of safety and quality along the entire value chain.

With our API and FDF business we serve in total over 400 customers worldwide. In our FDF business we develop, manufacture, and register generic, value added and innovative medicines and license them out to marketing partners worldwide. In our API business we distribute a full and complementary range of high-quality raw materials and value-added services to the European pharmaceutical industries.

The greatest strength of TIEFENBACHER GROUP are our people. We believe that their curiosity, their passion for healthcare, and their diversity are the driving force of achieving better health solutions. We welcome the diversity of nationalities, languages, cultures, and lifestyles in which we work together as one organization – that’s how we have a positive and effective impact on one another throughout the entire organization.

We are pioneering healthcare to improve patients´ lives around the world. Every year we serve over 500 million patients with our generic, value added and innovative products. All our activities are focused on creating pharmaceuticals – in a patient-centric approach – more available, more affordable, and better than before.

Our more than 800 employees at our locations in Germany, India and Cyprus come from over 20 different countries around the world. We believe that different personalities enrich us and we highly appreciate seeing things from different perspectives – a great environment to thrive and grow. Our unique company structure enables us to deliver high-quality pharmaceuticals worldwide and to contribute to a better tomorrow.

We believe that high-quality medicine should be affordable and available to everyone – irrespective of their income, their origin or their nationality. We also believe that there are always new ways of smart medicines which better deliver on patients ́ needs. That’s why all our activities are focused on creating pharmaceuticals more available, more affordable, and better than before. We drive everything from a patient-centered approach – in close collaboration and alignment with universities and key opinion leaders of all relevant medical disciplines.

We believe that we can only improve patients’ lives when we perform at our best together. That ́s why we concentrate with our 700 diverse, highly skilled employees worldwide our curiosity and passion and use our experience of almost 60 years in the pharmaceutical industry to deliver best-in-class solutions along the whole pharmaceutical value chain. By working together as TIEFENBACHER GROUP, in flexible and agile cross-functional structures, we tap into our full potential, drive our success, and stay at the forefront of our field.

We believe that the most important driver for our pioneering role is curiosity – the curiosity of each of our employees dedicated to make patients ́ life better. That ́s why we are always challenging the status quo and striving for novel healthcare solutions – in terms of business models as well as concrete products and services towards the benefit for patients.Thanks to the constant curiosity of our employees, we’ve always been pushing the boundaries of what’s possible, and we’ll continue to do so in the years to come.

Entrepreneurial thinking and flat hierarchies were already important to our inspiring founder, Alfred E. Tiefenbacher back in 1963. We still believe that true passion for what you do arises, when you can bring in your personality and your experiences in what you do. It gives you the courage and motivation to make decisions that help both you and the company move forward to improve patient’s live worldwide

Our healthcare business is developing dynamically and so are we. Therefore, we support our employees in permanently improving their own skills and strengths. We offer professional and need-based education, online and offline, to successfully meet current and future healthcare challenges. We believe that the access to affordable medicine is a human right.

The TIEFENBACHER GROUP is a family-owned healthcare company and is today owned by the direct descendants of the founding father Alfred E. Tiefenbacher. We put our passions to improve peoples’s live into action and want you to enjoy coming to work every day. Working at the TIEFENBACHER GROUP is characterized by mutual appreciation, fairness and transparency. A career with us means working for a company that values you and your well-being.

We are managing the entire innovative process to resolve development hurdles within a product lifecycle. We solve complex engineering challenges for medical devices to medical equipment engineering initiatives by working cross-site collaboration in the development processes, and the use of synergies. The control of all interfaces between medical device and drug product development including all necessary design verification and validation activities but also design transfer and process implementation is our key expertise and supports lean and efficient timelines and costs on the way to successful market access in our core regions EU + US.

We believe that better therapy and innovative medical devices as well as eHealth solutions does not necessarily mean higher costs. We guide and execute along a strategic pathway, focusing on product excellence, quality and regulatory compliance with patient-centric solutions that enhance the efficacy, safety and compliance of the treatments, for a controlled overall therapy cost.

We are certified to deal as a Legal Manufacturer together with ISO 13485-certified contract manufacturing partners and can provide full compliance to all lifecycle activities from batch release to post market surveillance as required per MDR 2017/745 within the healthcare market.

We ensure through certification a high level of safety and reliability for compliance with the legal requirements. Our certification confirms the effectiveness of our quality management system for design, development and manufacture of medical devices. We establish our processes in compliance with the current global regulations such as ISO 13485:2016 and MDR 2017/745.

We understand the regulatory and care environment in each respective region. Winning digital solutions cannot be developed as one-size-fits-all solutions. With evolving global regulations, establishing regulatory frameworks is of essential importance to drive successful practices and control strategies throughout the combination product lifecycle, to assure public health. We strive to continuously enhance our regulatory and quality expertise in the pharmaceutical and medical device industry.

We drive all players in the healthcare ecosystem to develop highly patient-centric solutions. We benefit from our global network of developing partners, analytical test houses, raw material suppliers, contract manufacturing partners, consultants and customers, which enables lean and well-organized development strategies and supports arranging new innovative and digital technologies.

We participate in a highly innovative segment to maximize patient outcomes while minimizing healthcare spends. Combination Products leave developing companies with various challenges and commercial risks with the interfaces between medical devices engineering and medicinal product development. As part of the TIEFENBACHER GROUP, we ensure reduced time to market by meeting all regulatory guidances and technical aspects. The skilled R&D and RA personnel significantly de-risk the product in early development, as well as reduce the number of questions from the reviewing agencies.

We contribute to the digital transformation and have the skills, knowledge, and power to tackle all critical issues and leverage the full potential in medical devices and eHealth. Interdisciplinary work is what characterizes us. Exchanging closely and making decisions quickly, we take this advantage to implement innovations very effectively. Our entrepreneurial spirit is a mindset that embraces critical questioning and continuous improvement.